Get the Stockscreener App
36.80
4.29%
-1.65
Pre-market:
36.39
-0.41
-1.11%
Twist Bioscience Corp stock is traded at $36.80, with a volume of 747.22K.
It is down -4.29% in the last 24 hours and down -13.08% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$38.45
Open:
$38.37
24h Volume:
747.22K
Relative Volume:
0.69
Market Cap:
$2.38B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-10.95
EPS:
-3.36
Net Cash Flow:
$-95.52M
1W Performance:
+0.46%
1M Performance:
-13.08%
6M Performance:
-19.16%
1Y Performance:
+28.81%
1-Day Range:
$36.58
$38.37
1-Week Range:
$36.07
$40.85
52-Week Range:
$27.41
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
36.80 | 2.38B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Is Twist Bioscience Corp (NASDAQ: TWST) A Good Pick For New Investors Now? - Stocksregister
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Alliancebernstein L.P. - Defense World
TWST LAWSUIT ALERT: Levi & Korsinsky Notifies Twist Bioscience Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com
LPL Financial LLC Has $2.32 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 - Business Wire
Barclays Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
Twist Bioscience CFO Sells Shares to Cover Tax Obligations - TradingView
Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.
Twist Bioscience (NASDAQ:TWST) Trading Down 12.1% After Analyst Downgrade - Defense World
Twist Bioscience president sells $7,978 in stock - Investing.com Australia
Twist Bioscience’s chief legal officer sells shares for $4,802 - Investing.com Australia
Twist Bioscience’s chief legal officer sells shares for $4,802 By Investing.com - Investing.com Canada
Twist Bioscience president sells $7,978 in stock By Investing.com - Investing.com Canada
Twist Bioscience CEO Sells Shares to Cover Tax Obligations - TradingView
KLP Kapitalforvaltning AS Takes Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics - Business Wire
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance
Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CEO Sells 1,726 Shares of Stock - MarketBeat
Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance
Twist Bioscience’s SVP of human resources sells $12,127 in stock - Investing.com India
Twist Bioscience CEO Emily Leproust sells $71,932 in shares By Investing.com - Investing.com South Africa
Twist Bioscience CEO Emily Leproust sells $71,932 in shares - Investing.com India
Twist Bioscience’s Dennis Cho sells $9,585 in common stock By Investing.com - Investing.com Canada
Twist Bioscience’s SVP of human resources sells $12,127 in stock By Investing.com - Investing.com Australia
Twist Bioscience’s Dennis Cho sells $9,585 in common stock - Investing.com
Twist Bioscience Corp (TWST) Shares Up 0.84% on Mar 21 - GuruFocus.com
Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy - Insider Monkey
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last? - Yahoo Finance
Twist Bioscience at Barclays Conference: Strategic Growth Amid Challenges - Investing.com
Victory Capital Management Inc. Boosts Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience at Leerink Conference: Strategic Growth Amid Challenges - Investing.com
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost - Business Wire
Twist Bioscience’s Dennis Cho sells $11,332 in stock - Investing.com India
Twist Bioscience CEO Emily Leproust sells shares worth $98,273 - Investing.com India
Twist Bioscience CEO Emily Leproust sells shares worth $98,273 By Investing.com - Investing.com Australia
Twist Bioscience’s Dennis Cho sells $11,332 in stock By Investing.com - Investing.com Australia
Twist Bioscience SVP Paula Green sells $37,558 in stock By Investing.com - Investing.com South Africa
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Bank of New York Mellon Corp Decreases Position in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Defies Skeptics With Strong Growth - Nanalyze
Twist Bioscience Corp (TWST) Shares Down 4.47% on Feb 7 - GuruFocus.com
Twist Bioscience director Robert Chess sells shares totaling $156,216 - MSN
Why Investors Shouldn't Be Surprised By Twist Bioscience Corporation's (NASDAQ:TWST) 26% Share Price Plunge - Simply Wall St
Twist Bioscience Co. (NASDAQ:TWST) Receives $54.40 Average Price Target from Brokerages - Defense World
Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? - Insider Monkey
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday - Benzinga
Handelsbanken Fonder AB Purchases New Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):